Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase and Carbapenemase-Producing Enterobacteriaceae Isolates from Bloodstream Infection Suspected Patients in Addis Ababa, Ethiopia

References

• Nijhuis R, van Zwet A, Stuart JC, Weijers T, Savelkoul P. Rapid molecular detection of extended-spectrum β-lactamase gene variants with a novel ligation-mediated real-time PCR. J Med Microbiol. 2012;61(11):1563–1567. doi:10.1099/jmm.0.047910-0
   Web of Science ®Google Scholar
• Siraj SM, Ali S, Wondafrash B. Extended-spectrum β-lactamase production in Klebsiella pneumoniae and Escherichia coli at Jimma University specialized hospital, south-west, Ethiopia. Mol Microbiol. 2015;5. doi:10.1186/s13756-019-0488-4
   Web of Science ®Google Scholar
• Palmeira JD, Ferreira HMN. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in cattle production–a threat around the world. Heliyon. 2020;6(1):e03206. doi:10.1016/j.heliyon.2020.e03206
   Web of Science ®Google Scholar
• Nepal K, Pant ND, Neupane B, et al. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):1–7. doi:10.1186/s12941-017-0236-7
   Web of Science ®Google Scholar
• Nedjai S, Barguigua A, Djahmi N, et al. Prevalence and characterization of extended spectrum beta-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med Mal Infect. 2012;42(1):20–29. doi:10.1016/j.medmal.2011.10.001
   Web of Science ®Google Scholar
• Tokajian S, Eisen JA, Jospin G, Farra A, Coil DA. Whole genome sequencing of extended-spectrum beta-lactamase producing Klebsiella pneumoniae isolated from a patient in Lebanon. Front Cell Infect Microbiol. 2015;5:32. doi:10.3389/fcimb.2015.00032
   Web of Science ®Google Scholar
• Siddiqui N, Bhakre J, Damle A, Bajaj J. Prevalence of extended-spectrum beta-lactamase (ESBL) producing gram-negative bacilli from various clinical isolates. IOSR J Dent Med Sci. 2014;13:186–189.
   Google Scholar
• Montazeri EA, Khosravi AD, Saki M, Sirous M, Keikhaei B, Seyed-Mohammadi S. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae causing bloodstream infections in cancer patients from southwest of Iran. Infect Drug Resist. 2020;13:1319. doi:10.2147/IDR.S254357
   Web of Science ®Google Scholar
• Ali T, Ali I, Khan NA, Han B, Gao J. The growing genetic and functional diversity of extended spectrum beta-lactamases. Biomed Res Int. 2018;2018. doi:10.1155/2018/9519718
   Web of Science ®Google Scholar
• Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(1):39. doi:10.1186/s13756-019-0488-4
   PubMed Web of Science ®Google Scholar
• Moges F, Setegn Eshetie WA, Mekonnen F, et al. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14(4):e0215177. doi:10.1371/journal.pone.0215177
   PubMed Web of Science ®Google Scholar
• Legese MH, Weldearegay GM, Asrat D. Extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae among Ethiopian children. Infect Drug Resist. 2017;10:27. doi:10.2147/IDR.S127177
   PubMed Web of Science ®Google Scholar
• Nakai H, Hagihara M, Kato H, et al. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. J Infect Chemother. 2016;22(5):319–326. doi:10.1016/j.jiac.2016.02.004
   Web of Science ®Google Scholar
• Hijazi SM, Fawzi MA, Ali FM, Abd el galil KH. Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon. JIDC. 2016;10(09):947–955. doi:10.3855/jidc.7593
   Web of Science ®Google Scholar
• Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia. Scand J Infect Dis. 2014;46(11):753–762. doi:10.3109/00365548.2014.937454
   PubMed Web of Science ®Google Scholar
• Hijazi S, Fawzi M, Ali F, Abd el galil K. Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors. Ann Clin Microbiol Antimicrob. 2016;15(1):1–9. doi:10.1186/s12941-016-0121-9
   PubMed Web of Science ®Google Scholar
• Sheikh AF, Khoshnood S, Saki M, et al. Prevalence of carbapenemases and ESBL encoding genes among K. pneumoniae isolates obtained from an educational hospital in Ahvaz, Southwestern Iran. Gene Rep. 2021;23:101128. doi:10.1016/j.genrep.2021.101128
   Web of Science ®Google Scholar
• Manageiro V, Romão R, Moura IB, et al. Molecular epidemiology and risk factors of carbapenemase-producing Enterobacteriaceae isolates in Portuguese hospitals: results from European survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE). Front Microbiol. 2018;9:2834. doi:10.3389/fmicb.2018.02834
   Web of Science ®Google Scholar
• Dortet L, Cuzon G, Ponties V, Nordmann P. Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014. Eurosurveillance. 2017;22(6):30461. doi:10.2807/1560-7917.ES.2017.22.6.30461
   Web of Science ®Google Scholar
• Nordmann P, Gniadkowski M, Giske C, et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. CMI. 2012;18(5):432–438. doi:10.1111/j.1469-0691.2012.03815.x
   Web of Science ®Google Scholar
• Wilson H, Török ME. Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae. Microbial Genom. 2018;4:7.
   Web of Science ®Google Scholar
• Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, et al. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One. 2017;12(11):e0187832. doi:10.1371/journal.pone.0187832
   Web of Science ®Google Scholar
• Tadesse S, Mulu W, Genet C, Kibret M, Belete MA, Mascellino MT. Emergence of high prevalence of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae species among patients in Northwestern Ethiopia Region. Biomed Res Int. 2022;2022:1–9. doi:10.1155/2022/5727638
   Web of Science ®Google Scholar
• Onken A, Said AK, Jørstad M, Jenum PA, Blomberg B, Galdiero M. Prevalence and antimicrobial resistance of microbes causing bloodstream infections in Unguja, Zanzibar. PLoS One. 2015;10(12):12. doi:10.1371/journal.pone.0145632
   Web of Science ®Google Scholar
• Leal HF, Azevedo J, Silva GEO, et al. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features. BMC Infect Dis. 2019;19(1):609. doi:10.1186/s12879-019-4265-z
   Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Sfeir M, Satlin M, Fauntleroy K, Jenkins S, Westblade L. Blood-modified carbapenem inactivation method: a phenotypic method for detecting carbapenemase-producing Enterobacteriaceae directly from positive blood culture broths. J Clin Microbiol. 2020;58(2):e01377–01319. doi:10.1128/JCM.01377-19
   Web of Science ®Google Scholar
• Mohammed Y, Gadzama GB, Zailani SB, Aboderin AO. Characterization of extended-spectrum beta-lactamase from Escherichia coli and Klebsiella species from North Eastern Nigeria. J Clin Diagnostic Res. 2016;10(2):DC07.
   Google Scholar
• Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.002
   PubMed Web of Science ®Google Scholar
• Darweesh MF. Molecular characterization of ESBL gene in Citrobacter spp. and antibacterial activity of omega-3 against resistant isolates. Curr Issues Pharm Med Sci. 2017;30(3):156–161. doi:10.1515/cipms-2017-0029
   Web of Science ®Google Scholar
• Kakru DK, Khurshid S, Arshi S. Prevalence of carbapenemase producing genes among carbapenem resistant enterobacteriaceae isolated from blood in a Tertiary Care Hospital, Kashmir. Int J Curr Microbiol App Sci. 2019;8(4):2859–2865. doi:10.20546/ijcmas.2019.804.333
   Google Scholar
• KdS N, Conte D, Maia FV, Dalla-Costa LM. Distribution of extended-spectrum β-lactamase types in a Brazilian tertiary hospital. Rev Soc Bras Med Trop. 2015;48(2):162–169. doi:10.1590/0037-8682-0009-2015
   Web of Science ®Google Scholar
• Garza-Gonzalez E, Ibarra SIM, Llaca-Díaz JM, Gonzalez GM. Molecular characterization and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. J Med Microbiol. 2011;60(1):84–90. doi:10.1099/jmm.0.022970-0
   Web of Science ®Google Scholar
• Muro S, Garza-González E, Camacho-Ortiz A, et al. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Chemotherapy. 2012;58(3):217–224. doi:10.1159/000339483
   Web of Science ®Google Scholar
• Rakotonirina HC, Garin B, Randrianirina F, Richard V, Talarmin A, Arlet G. Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiol. 2013;13(1):85. doi:10.1186/1471-2180-13-85
   Web of Science ®Google Scholar
• Ibadin EE, Omoregie R, Anogie NA, Igbarumah IO, Ogefere HO. Prevalence of extended spectrum β-lactamase, ampC β-lactamase and metallo-β-lactamase among gram negative bacilli recovered from clinical specimens in Benin city, Nigeria. Int J Enteric Pathog. 2017;5(3):85–91. doi:10.15171/ijep.2017.20
   Google Scholar
• Abdallah H, Wintermans B, Reuland E, et al. Extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection. PLoS One. 2015;10(5):e0128120. doi:10.1371/journal.pone.0128120
   Web of Science ®Google Scholar
• Schmiedel J, Falgenhauer L, Domann E, et al. Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC Microbiol. 2014;14(1):187. doi:10.1186/1471-2180-14-187
   Web of Science ®Google Scholar
• Vlieghe ER, Huang T-D, Phe T, et al. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia. Eur J Clin Microbiol Infect Dis. 2015;34(6):1223–1229. doi:10.1007/s10096-015-2350-9
   Web of Science ®Google Scholar
• Rani DS, Jahnavi DI, Nagamani DK. Phenotypic and molecular characterization of ESBL producing Enterobacteriaceaein A Tertiary Care Hospital. IOSR-JDMS. 2016;15(08):27–34. doi:10.9790/0853-1508092734
   Google Scholar
• Desta K, Woldeamanuel Y, Azazh A, et al. High gastrointestinal colonization rate with extended-spectrum beta-lactamase-producing enterobacteriaceae in hospitalized patients: emergence of carbapenemase-producing K. pneumoniae in Ethiopia. PLoS One. 2016;11(8):e0161685. doi:10.1371/journal.pone.0161685
   Web of Science ®Google Scholar
• Khaertynov KS, Anokhin VA, Rizvanov AA, et al. Virulence factors and antibiotic resistance of Klebsiella pneumoniae strains isolated from neonates with sepsis. Front Med. 2018;5:225. doi:10.3389/fmed.2018.00225
   Web of Science ®Google Scholar
• Poirel L, Madec J-Y, Lupo A, et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018;6(4):6.4.14. doi:10.1128/microbiolspec.ARBA-0026-2017
   PubMed Web of Science ®Google Scholar
• Wartitima EL, Bahmani F-Z, Elouennass M, Benouda A. Prevalence of carbapenemase-producing Enterobacteriaceae in a University Hospital in Rabat, Morocco: a 19-months prospective study. Int Arab J Antimicrob Agents. 2012;2(3):1–6.
   Google Scholar
• Taqi M, Jamal W, Rotimi V. The prevalence of Extended-Spectrum β-lactamase (ESBL)-and Carbapenem–Resistant Enterobacteriaceae (CRE) isolates in positive blood cultures of patients in a teaching hospital in Kuwait over a 2-year period. Paper presented at: Open Forum Infectious Diseases; 2017.
   Google Scholar
• Devi LS, Broor S, Rautela RS, Grover SS, Chakravarti A, Chattopadhya D. Increasing prevalence of Escherichia coli and Klebsiella pneumoniae producing CTX-M-type extended-spectrum beta-lactamase, carbapenemase, and NDM-1 in patients from a rural community with community acquired infections: a 3-year study. Int J Bppl Basic Med. 2020;10(3):156.
   Web of Science ®Google Scholar
• Lai -C-C, Wu U-I, Wang J-T, Chang S-C. Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan. JFMA. 2013;112(8):492–496.
   Google Scholar
• Hrabák J, Študentová V, Jakubů V, et al. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals–results from Czech Part of European Survey on Carbapenemase–Producing Enterobacteriaceae (EuSCAPE). Epidemiol Mikrobiol Imunol. 2015;64(2):87–91.
   Web of Science ®Google Scholar
• Okoche D, Asiimwe BB, Katabazi FA, Kato L, Najjuka CF. Prevalence and characterization of carbapenem-resistant Enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda. PLoS One. 2015;10(8):e0135745. doi:10.1371/journal.pone.0135745
   Web of Science ®Google Scholar
• Kaase M, Schimanski S, Schiller R, et al. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals. Int J Med Microbiol. 2016;306(6):415–420. doi:10.1016/j.ijmm.2016.05.009
   Web of Science ®Google Scholar
• Villegas MV, Pallares CJ, Escandón-Vargas K, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American countries. PLoS One. 2016;11(4):e0154092. doi:10.1371/journal.pone.0154092
   PubMed Web of Science ®Google Scholar
• Uddin F, Imam SH, Khan S, et al. NDM production as a dominant feature in carbapenem-resistant Enterobacteriaceae isolates from a Tertiary Care Hospital. Antibiotics. 2022;11(1):48. doi:10.3390/antibiotics11010048
   Web of Science ®Google Scholar
• Ouedraogo AS, Sanou M, Kissou A, et al. High prevalence of extended-spectrum ss-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(1):326. doi:10.1186/s12879-016-1655-3
   Web of Science ®Google Scholar
• Hassan H, Abdalhamid B. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital. J Infect Dev Ctries. 2014;8(3):282–288. doi:10.3855/jidc.3809
   Web of Science ®Google Scholar
• Salah FD, Soubeiga ST, Ouattara AK, et al. Distribution of quinolone resistance gene (qnr) in ESBL-producing Escherichia coli and Klebsiella spp. in Lomé, Togo. Antimicrob Resist Infect Control. 2019;8(1):1–8. doi:10.1186/s13756-019-0552-0
   Web of Science ®Google Scholar
• Park J-W, Lee H, Park SY, Kim TH. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea. Antimicrob Resist Infect Control. 2019;8(1):1–9. doi:10.1186/s13756-019-0497-3
   Web of Science ®Google Scholar
• Parajuli NP, Maharjan P, Joshi G, Khanal PR. Emerging perils of extended spectrum beta-lactamase producing enterobacteriaceae clinical isolates in a teaching hospital of Nepal. Biomed Res Int. 2016;2016:1782835. doi:10.1155/2016/1782835
   Web of Science ®Google Scholar
• Karabay O, Altindis M, Koroglu M, Karatuna O, Aydemir ÖA, Erdem AF. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey. Ann. Clin. Microbiol. Antimicrob. 2016;15(1):1–6. doi:10.1186/s12941-016-0118-4
   Web of Science ®Google Scholar
• Jain A, Hopkins KL, Turton J, et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother. 2014;69(7):1777–1784. doi:10.1093/jac/dku084
   PubMed Web of Science ®Google Scholar
• Khan AU, Maryam L, Zarrilli R. Structure, genetics and worldwide spread of New Delhi metallo-β-lactamase (NDM): a threat to public health. BMC Microbiol. 2017;17(1):1–12. doi:10.1186/s12866-017-1012-8
   PubMed Web of Science ®Google Scholar
• Vlek A, Frentz D, Haenen A, et al. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013–2014. Eur J Clin Microbiol Infect Dis. 2016;35(7):1089–1096. doi:10.1007/s10096-016-2636-6
   Web of Science ®Google Scholar
• Rimrang B, Chanawong A, Lulitanond A, et al. Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand. J Antimicrob Chemother. 2012;67(11):2626–2630. doi:10.1093/jac/dks267
   PubMed Web of Science ®Google Scholar